Talaris Therapeutics Inc

NASDAQ:TALS   3:58:00 PM EDT
14.01
-0.12 (-0.85%)
Earnings Announcements

Talaris Therapeutics Announces Q1 Loss Per Share Of $1.30

Published: 06/14/2021 21:33 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update.
Q1 Loss per Share $1.30.
Talaris Therapeutics - Finished Q1 With $140.1 Million in Cash, Cash Equivalents, Marketable Securities Compared With $149.5 Million As of December 31, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.